Global Tuberculosis Trends in 2022
Tuberculosis is part of Infectious Disease. You may also be interested in HIV AIDS, Influenza and Malaria.
Global TB prevalence rose to 6.3 million cases in 2014, up from 6.1 million cases in 2013, according to World Health Organization data. This marks a year-on-year increase.
Tuberculosis Market Data and Forecasts
How much the Tuberculosis industry is expected to grow?
More in Tuberculosis Industry for 2027Global Tuberculosis Statistics
- Tuberculosis Mortality 232 countries (Europe, Southern Europe, Northern Europe...)
- Tuberculosis Prevalence 236 countries (Africa, Sub-Saharan Africa, Asia...)
- Tuberculosis Incidence 238 countries (Africa, Sub-Saharan Africa, Asia...)
- Tuberculosis Treatment Success Rate 230 countries (Africa, Sub-Saharan Africa, Asia...)
- Tuberculosis Treatment Coverage 221 countries (Africa, Sub-Saharan Africa, Asia...)
Global Tuberculosis Industry Database
Improve your Knowledge with the latest Indicators and Trends
-
Pharmaceutics Impact: Delving Into the Global Tuberculosis Treatment Drugs Market Landscape
Growing demands for more effective treatments in response to the expanding global tuberculosis (TB) burden have marked the present landscape of the TB drugs market. Constant advancements in research and development have led to the introduction of novel products, while the presence of robust distribution networks facilitates reach to global...
Discover more insights -
Interlinking Insights: Tuberculosis and Tissue Diagnostics - Vital Developments and Market Dynamics
Key market dynamics in the realm of tuberculosis diagnostics are driven by a heightened global incidence of tuberculosis and increasing demand for fast and accurate diagnostic tests. Improved diagnostic techniques, driven largely by technology advancements, are reinventing the landscape of tuberculosis diagnosis. These developments, alongside expanding awareness about the disease,...
Discover more insights -
Infectious Disease Battles: Advancements and Trends in Burkholderia Infections Drug Development
Current medical strategies to combat Burkholderia infections, a serious health risk attributed to their intrinsic antibiotic resistance, are often faced with substantial challenges. Existing pharmaceutical interventions are generally less than optimally effective, with recurrent infection and treatment resistance frequently observed. Hence, the hunt for novel and efficacious drug therapies remains...
Discover more insights